$225m to advance novel immune checkpoint enhancer programme
Drug Discovery World
MAY 23, 2024
The funds will be used to support ongoing and planned Phase II clinical trials in ulcerative colitis (UC), one of many immunological disorders where the mechanism has been clinically validated. This study is anticipated to read out in 2H of 2026.
Let's personalize your content